The FDA has started a priority review of X4 Pharma’s mavorixafor, angling to become the first therapy for the rare disease WHIM syndrome, with a decision due by 30th April next year. WHIM (warts ...

Punsammi, 54, of Whim Village, Corentyne lost his house on Friday March 28th, 2025 forcing him to take up abode at his daughter’s house. Regional Vice-Chairman, Zamal Hussain, on Thursday, met with ...